Facebook tracking pixel
S10.AI
ICD-10-CM · U07.1GeneralSystemic

COVID-19 Infection

Find comprehensive information on COVID-19 Infection diagnosis, including clinical documentation, medical coding, and healthcare guidance. Learn about Coronavirus Disease 2019 and SARS-CoV-2 Infection, covering symptoms, testing, treatment, and ICD-10 codes for accurate reporting. This resource supports healthcare professionals in proper COVID-19 diagnosis documentation and coding practices.

Also known as
Coronavirus Disease 2019SARS-CoV-2 Infection
Definition

Viral respiratory illness caused by SARS-CoV-2.

Clinical signs

Fever, cough, shortness of breath, fatigue, loss of taste or smell.

Common settings

Community-acquired, travel-related, close contact exposure.

Related Codes

ICD-10 Code Families

Complete code families applicable to U07.1

U07.1
COVID-19, virus identified
U07.2
COVID-19, virus not identified
J12.81
Pneumonia due to COVID-19
B97.29
Other coronavirus as the cause of diseases classified elsewhere
Code Comparison

When to use each related code

DescriptionWhen to use
COVID-19 viral infectionConfirmed SARS-CoV-2 infection by PCR or antigen test. Use for active or recent infection.
Influenza viral infectionConfirmed influenza virus infection. Specify type if known (e.g., influenza A). Use for active infection.
Acute respiratory infectionUse for undifferentiated respiratory infections when a specific etiology is not yet identified.
Documentation

Best-practice checklist

  • Document COVID-19 symptoms: fever, cough, shortness of breath.
  • Record symptom onset date for accurate COVID-19 diagnosis coding.
  • Specify COVID-19 diagnostic test type and results (PCR, antigen).
  • Document COVID-19 disease severity (mild, moderate, severe).
  • Note any COVID-19 related complications or comorbidities.
Coding & Audit Risks

Common pitfalls to avoid

Unspecified COVID-19

Coding COVID-19 without specifying confirmed, suspected, or ruled out status can lead to inaccurate reporting and reimbursement.

Comorbidity Coding

Accurate capture of comorbidities with COVID-19 is crucial for risk adjustment and severity reflection. Missing codes impacts quality metrics.

Sequencing Errors

Incorrect sequencing of COVID-19 with other diagnoses can affect DRG assignment and reimbursement, especially with respiratory conditions.

Mitigation

Best-practice tips

  • 01Isolate immediately to prevent COVID-19 transmission. Document isolation status.
  • 02Ensure accurate COVID-19 diagnosis codes (U07.1, U07.2) for proper reimbursement.
  • 03Follow current CDC guidelines for COVID-19 testing and treatment protocols.
  • 04Monitor patient symptoms and document disease severity for accurate coding.
  • 05Implement infection control measures. Adhere to healthcare compliance regulations.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Verify patient symptoms: fever, cough, shortness of breath, loss of taste/smell (ICD-10 U07.1, U07.2)

  2. 2

    Confirm with PCR or antigen test (CPT 87635, 87426). Document test type/result.

  3. 3

    Assess severity: mild, moderate, severe, critical (e.g., oxygen saturation, respiratory rate).

  4. 4

    Review comorbidities: document underlying conditions (e.g., diabetes, hypertension) impacting prognosis.

Documentation Template

Ready-to-paste narrative

Patient presents with complaints consistent with COVID-19 infection, also known as Coronavirus Disease 2019 and SARS-CoV-2 infection.  Symptoms onset began [Date of symptom onset] and include [List specific symptoms e.g., cough, fever, shortness of breath, fatigue, loss of taste or smell, body aches, sore throat, headache, congestion or runny nose, nausea or vomiting, diarrhea].  Patient reports [mention any relevant exposures, recent travel, or contact with known COVID-19 cases].  Vital signs recorded as temperature [Temperature] degrees Fahrenheit, heart rate [Heart Rate] bpm, respiratory rate [Respiratory Rate] breaths per minute, blood pressure [Blood Pressure] mmHg, and oxygen saturation [Oxygen Saturation]% on room air.  Physical examination reveals [Document relevant physical findings e.g., clear lung sounds, mild pharyngeal erythema].  Differential diagnoses considered include influenza, other viral respiratory infections, and pneumonia.  Based on presenting symptoms, exposure history, and clinical findings, a presumptive diagnosis of COVID-19 is made.  A SARS-CoV-2 PCR test was ordered.  Patient advised on supportive care including rest, hydration, and over-the-counter medications for symptom management such as acetaminophen or ibuprofen for fever and body aches.  Patient educated on isolation precautions, including quarantine guidelines per CDC recommendations, to prevent further transmission.  Follow-up scheduled for [Date of follow-up] to review test results and assess symptom progression.  ICD-10-CM code U07.1 is documented for COVID-19.  Treatment plan documented and communicated to the patient.  Medical billing and coding reviewed for accuracy.
FAQs

Common questions and answers

What are the most current evidence-based guidelines for managing severe COVID-19 infection in hospitalized patients, including ventilator management and thromboembolism prophylaxis?+

Managing severe COVID-19 infection requires a multifaceted approach based on the most up-to-date clinical guidelines. For hospitalized patients, oxygen supplementation is crucial, with mechanical ventilation considered for those with worsening hypoxemic respiratory failure. Current recommendations emphasize lung-protective ventilation strategies, including low tidal volumes and optimal PEEP settings, to minimize ventilator-induced lung injury. Thromboembolism prophylaxis is another cornerstone of severe COVID-19 management. Guidelines recommend pharmacologic prophylaxis, such as low-molecular-weight heparin, for most hospitalized patients, unless contraindicated. Additionally, corticosteroids like dexamethasone have shown benefit in reducing mortality in patients requiring supplemental oxygen. Explore how our platform integrates real-time updates on COVID-19 management guidelines to ensure optimal patient care.

How can clinicians differentiate between COVID-19 pneumonia and other viral or bacterial pneumonias using clinical presentation, laboratory findings, and imaging studies, and when should I suspect co-infection?+

Differentiating COVID-19 pneumonia from other respiratory infections can be challenging due to overlapping symptoms. While clinical presentation may include fever, cough, and shortness of breath common to many respiratory illnesses, some features may raise suspicion for COVID-19, such as loss of taste or smell. Laboratory findings, including PCR testing for SARS-CoV-2, are essential for definitive diagnosis. Imaging studies, particularly chest CT scans, can reveal characteristic ground-glass opacities or consolidations often seen in COVID-19 pneumonia, but these findings are not always specific. Co-infection with other bacterial or viral pathogens can occur in COVID-19 patients and should be suspected in individuals with atypical presentations or worsening clinical course. Consider implementing a comprehensive diagnostic approach that incorporates clinical findings, laboratory testing, and imaging to accurately differentiate COVID-19 pneumonia and identify potential co-infections. Learn more about the diagnostic tools available to enhance your clinical decision-making in respiratory infections.

What are the long-term sequelae of COVID-19 infection (long COVID), including cardiovascular, pulmonary, and neurological complications, and what strategies are recommended for patient follow-up and management?+

Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), encompasses a wide range of persistent symptoms and complications that can affect multiple organ systems. Cardiovascular complications can include myocarditis, pericarditis, and arrhythmias. Pulmonary sequelae may manifest as persistent cough, dyspnea, and reduced lung function. Neurological complications can range from cognitive impairment (brain fog) and fatigue to peripheral neuropathy and mood disorders. Given the diverse and often debilitating nature of long COVID, comprehensive patient follow-up is crucial. Strategies for management should be individualized based on the specific symptoms and complications experienced by each patient and may involve multidisciplinary care including pulmonary rehabilitation, cardiac evaluation, and neuropsychological assessment. Explore how our resources can support clinicians in providing comprehensive care for patients with long COVID and addressing the multifaceted challenges of this evolving condition.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.